Immunopathology and dexamethasone therapy in a new model for malaria-associated acute respiratory distress syndrome

American Journal of Respiratory and Critical Care Medicine

Volumn 181, Issue 9, 2010, Pages 957-968

  Van Den Steen, Philippe E ^a   Geurts, Nathalie ^a   Deroost, Katrien ^a   Van Aelst, Ilse ^a   Verhenne, Sebastien ^a   Heremans, Hubertine ^a   Van Damme, Jo ^a   Opdenakker, Ghislain ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

CD8+ T lymphocyte; Chemokine; Cytokine; Glucocorticoid; Plasmodium berghei NK65

Indexed keywords

CHEMOKINE; CYTOKINE; DEXAMETHASONE SODIUM PHOSPHATE; DEXAMETHASONE;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN MALARIA; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNOPATHOLOGY; LEUKOCYTE; LUNG EDEMA; LUNG HEMORRHAGE; LUNG LAVAGE; LUNG WEIGHT; LYMPHOCYTE DEPLETION; MALARIA; MONOCYTE; MOUSE; NONHUMAN; PATHOGENESIS; PLASMODIUM BERGHEI; PLASMODIUM CHABAUDI; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; TREATMENT RESPONSE; ANIMAL; BLEEDING; C57BL MOUSE; CYTOLOGY; DISEASE MODEL; EDEMA; HYPOALBUMINEMIA; IMMUNOLOGY; LUNG; LYMPHOCYTE COUNT; MACROPHAGE; METABOLISM; PATHOLOGY; PHYSIOLOGY; REGULATORY T LYMPHOCYTE; SPLEEN; T LYMPHOCYTE;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINES; CYTOKINES; DEXAMETHASONE; DISEASE MODELS, ANIMAL; EDEMA; HEMORRHAGE; HYPOALBUMINEMIA; LUNG; LYMPHOCYTE COUNT; MACROPHAGES; MALARIA; MICE; MICE, INBRED C57BL; PLASMODIUM BERGHEI; RESPIRATORY DISTRESS SYNDROME, ADULT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 77952298693     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200905-0786OC     Document Type: Article

References (50)

1. White NJ. Qinghaosu (artemisinin): the price of success. Science 2008;320:330-334.
2. Schofield L, Grau GE. Immunological processes in malaria pathogenesis. Nat Rev Immunol 2005;5:722-735.
3. + T cells in experimental cerebral malaria. J Immunol 2002;169:6369-6375.
4. Yanez DM, Manning DD, Cooley AJ, Weidanz WP, van der Heyde HC. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J Immunol 1996;157:1620-1624.
5. + T lymphocytes mediate experimental cerebral malaria pathogenesis. J Immunol 2003;170:2221-2228.
6. Miu J, Mitchell AJ, Muller M, Carter SL, Manders PM, McQuillan JA, Saunders BM, Ball HJ, Lu B, Campbell IL, et al. Chemokine gene expression during fatal murine cerebral malaria and protection due to CXCR3 deficiency. J Immunol 2008;180:1217-1230.
7. Van den Steen PE, Deroost K, Van Aelst I, Geurts N, Martens E, Struyf S, Nie CQ, Hansen DS, Matthys P, Van Damme J, et al. CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN-γ-induced chemokines. Eur J Immunol 2008;38:1082-1095.
8. Campanella GS, Tager AM, El Khoury JK, Thomas SY, Abrazinski TA, Manice LA, Colvin RA, Luster AD. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Proc Natl Acad Sci USA 2008;105:4814-4819.
9. Srivastava K, Cockburn IA, Swaim A, Thompson LE, Tripathi A, Fletcher CA, Shirk EM, Sun H, Kowalska MA, Fox-Talbot K, et al. Platelet factor 4 mediates inflammation in experimental cerebral malaria. Cell Host Microbe 2008;4:179-187.
10. Taylor WR, White NJ. Malaria and the lung. Clin Chest Med 2002;23:457-468.
11. Taylor WR, Canon V, White NJ. Pulmonary manifestations of malaria: recognition and management. Treat Respir Med 2006;5:419-428.
12. Mohan A, Sharma SK, Bollineni S. Acute lung injury and acute respiratory distress syndrome in malaria. J Vector Borne Dis 2008;45:179-193.
13. Tan LK, Yacoub S, Scott S, Bhagani S, Jacobs M. Acute lung injury and other serious complications of Plasmodium vivax malaria. Lancet Infect Dis 2008;8:449-454.
14. Valecha N, Pinto RG, Turner GD, Kumar A, Rodrigues S, Dubhashi NG, Rodrigues E, Banaulikar SS, Singh R, Dash AP, et al. Histopathology of fatal respiratory distress caused by Plasmodium vivax malaria. Am J Trop Med Hyg 2009;81:758-762.
15. Charoenpan P, Indraprasit S, Kiatboonsri S, Suvachittanont O, Tanomsup S. Pulmonary edema in severe falciparum malaria: hemodynamic study and clinicophysiologic correlation. Chest 1990;97:1190-1197.
16. Corbett CE, Duarte MI, Lancellotti CL, Silva MA, Andrade HF Jr. Cytoadherence in human falciparum malaria as a cause of respiratory distress. J Trop Med Hyg 1989;92:112-120.
17. Duarte MI, Corbett CE, Boulos M, Amato NV. Ultrastructure of the lung in falciparum malaria. Am J Trop Med Hyg 1985;34:31-35.
18. MacPherson GG, Warrell MJ, White NJ, Looareesuwan S, Warrell DA. Human cerebral malaria: a quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am J Pathol 1985;119:385-401.
19. Senaldi G, Vesin C, Chang R, Grau GE, Piguet PF. Role of polymorphonuclear neutrophil leukocytes and their integrin CD11a (LFA-1) in the pathogenesis of severe murine malaria. Infect Immun 1994;62:1144-1149.
20. Cordeiro RS, Cunha FQ, Filho JA, Flores CA, Vasconcelos HN, Martins MA. Plasmodium berghei: physiopathological changes during infections in mice. Ann Trop Med Parasitol 1983;77:455-465.
21. Favre N, Da Laperousaz C, Ryffel B, Weiss NA, Imhof BA, Rudin W, Lucas R, Piguet PF. Role of ICAM-1 (CD54) in the development of murine cerebral malaria. Microbes Infect 1999;1:961-968.
22. Piguet PF, Da Laperrousaz C, Vesin C, Tacchini-Cottier F, Senaldi G, Grau GE. Delayed mortality and attenuated thrombocytopenia associated with severe malaria in urokinase- and urokinase receptor-deficient mice. Infect Immun 2000;68:3822-3829. (Pubitemid 30434528)
23. Carvalho LJ, Lenzi HL, Pelajo-Machado M, Oliveira DN, Daniel-Ribeiro CT, Ferreira-da-Cruz MF. Plasmodium berghei: cerebral malaria in CBA mice is not clearly related to plasma TNF levels or intensity of histopathological changes. Exp Parasitol 2000;95:1-7.
24. Piguet PF, Kan CD, Vesin C, Rochat A, Donati Y, Barazzone C. Role of CD40-CVD40L in mouse severe malaria. Am J Pathol 2001;159:733-742.
25. Chang WL, Jones SP, Lefer DJ, Welbourne T, Sun G, Yin L, Suzuki H, Huang J, Granger DN, van der Heyde HC. CD81-T-cell depletion ameliorates circulatory shock in Plasmodium berghei-infected mice. Infect Immun 2001;69:7341-7348.
26. Piguet PF, Kan CD, Vesin C. Role of the tumor necrosis factor receptor 2 (TNFR2) in cerebral malaria in mice. Lab Invest 2002;82:1155-1166.
27. Chang WL, Li J, Sun G, Chen HL, Specian RD, Berney SM, Granger DN, van der Heyde HC. P-selectin contributes to severe experimental malaria but is not required for leukocyte adhesion to brain microvasculature. Infect Immun 2003;71:1911-1918. (Pubitemid 36368723)
28. Li J, Chang WL, Sun G, Chen HL, Specian RD, Berney SM, Kimpel D, Granger DN, van der Heyde HC. Intercellular adhesion molecule 1 is important for the development of severe experimental malaria but is not required for leukocyte adhesion in the brain. J Investig Med 2003;51:128-140. (Pubitemid 36554771)
29. Togbe D, Schofield L, Grau GE, Schnyder B, Boissay V, Charron S, Rose S, Beutler B, Quesniaux VF, Ryffel B. Murine cerebral malaria development is independent of Toll-like receptor signaling. Am J Pathol 2007;170:1640-1648.
30. Lovegrove FE, Gharib SA, Pena-Castillo L, Patel SN, Ruzinski JT, Hughes TR, Liles WC, Kain KC. Parasite burden and CD36-mediated sequestration are determinants of acute lung injury in an experimental malaria model. PLoS Pathog 2008;4:e1000068.
31. Franke-Fayard B, Janse CJ, Cunha-Rodrigues M, Ramesar J, Buscher P, Que I, Lowik C, Voshol PJ, den Boer MA, van Duinen SG, et al. Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration. Proc Natl Acad Sci USA 2005;102:11468-11473.
32. Schofield L, Hewitt MC, Evans K, Siomos MA, Seeberger PH. Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria. Nature 2002;418:785-789.
33. Van den Steen PE, Van Aelst I, Verhenne S, Geurts N, Deroost K, Van Damme J, Opdenakker G. Cytokine/chemokine-mediated immunopathology and dexamethasone therapy in a new model for malariaassociated acute respiratory distress syndrome [abstract]. Eur J Immunol 2009;39:S53.
34. Taub DD, Proost P, Murphy WJ, Anver M, Longo DL, Van Damme J, Oppenheim JJ. Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J Clin Invest 1995;95:1370-1376.
35. Hansen DS, Evans KJ, D'Ombrain MC, Bernard NJ, Sexton AC, Buckingham L, Scalzo AA, Schofield L. The natural killer complex regulates severe malarial pathogenesis and influences acquired immune responses to Plasmodium berghei ANKA. Infect Immun 2005;73:2288-2297.
36. Grau GE, Fajardo LF, Piguet PF, Allet B, Lambert PH, Vassalli P. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 1987;237:1210-1212.
37. Andrade HF Jr, Corbett CE, Laurenti MD, Duarte MI. Comparative and sequential histopathology of Plasmodium chabaudi-infected Balb/c mice. Braz J Med Biol Res 1991;24:1209-1218.
38. Maguire GP, Handojo T, Pain MC, Kenangalem E, Price RN, Tjitra E, Anstey NM. Lung injury in uncomplicated and severe falciparum malaria: a longitudinal study in Papua, Indonesia. J Infect Dis 2005;192:1966-1974.
39. + T cell migration to the brain by IFN-γ during experimental cerebral malaria. Parasite Immunol 2008;30:544-553.
40. Neill AL, Hunt NH. Effects of endotoxin and dexamethasone on cerebral malaria in mice. Parasitology 1995;111:443-454.
41. Warrell DA, Looareesuwan S, Warrell MJ, Kasemsarn P, Intaraprasert R, Bunnag D, Harinasuta T. Dexamethasone proves deleterious in cerebral malaria: a double-blind trial in 100 comatose patients. N Engl J Med 1982;306:313-319.
42. Hoffman SL, Rustama D, Punjabi NH, Surampaet B, Sanjaya B, Dimpudus AJ, McKee KT Jr, Paleologo FP, Campbell JR, Marwoto H. High-dose dexamethasone in quinine-treated patients with cerebral malaria: a double-blind, placebo-controlled trial. J Infect Dis 1988;158:325-331.
43. Adcock IM. Molecular mechanisms of glucocorticosteroid actions. Pulm Pharmacol Ther 2000;13:115-126.
44. Goulding NJ. The molecular complexity of glucocorticoid actions in inflammation: a four-ring circus. Curr Opin Pharmacol 2004;4:629-636.
45. Tuckermann JP, Kleiman A, McPherson KG, Reichardt HM. Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis. Crit Rev Clin Lab Sci 2005;42:71-104.
46. Yang M, Kumar RK, Foster PS. Pathogenesis of steroid-resistant airway hyperresponsiveness: interaction between IFN-γ and TLR4/MyD88 pathways. J Immunol 2009;182:5107-5115.
47. + regulatory T cells. Nat Med 2004;10:29-30.
48. + T cells expand during experimental Plasmodium infection but do not prevent cerebral malaria. Int J Parasitol 2007;37:963-973.
49. Couper KN, Blount DG, Wilson MS, Hafalla JC, Belkaid Y, Kamanaka M, Flavell RA, de Souza JB, Riley EM. IL-10 from CD4CD25Foxp3CD127 adaptive regulatory T cells modulates parasite clearance and pathology during malaria infection. PLoS Pathog 2008;4:e1000004.
50. Laplante C, Giroud CJ, Stachenko J. Lack of appreciable 17-α-hydroxylase activity in the normal and regenerated rat adrenal cortex. Endocrinology 1964;75:825-827.